American Society for Transplantation & Cellular Therapy

Analysis

American Society for Transplantation & Cellular Therapy is a registered charity in United States, based in Chicago, IL. It received its IRS tax-exemption ruling in August 1994, 32 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, American Society for Transplantation & Cellular Therapy reported income of $8.1m and spending of $8.3m, spending 103% of its income. Across the 6 years on record, from December 2018 to December 2023, income grew from $4.5m to $8.1m (+82%), an average of +13% a year. The sharpest change came in the year to December 2022, when income rose by 37%. Over the whole period it spent 89% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, American Society for Transplantation & Cellular Therapy sits at the 83rd percentile: it is larger than about 82% of them. Against every charity in United States with reported income it ranks in the 94th percentile, and in the 94th percentile within IL. Charities of a similar size with the same main cause include St Rose Dominican Health Foundation ($8.1m), My Brothers Keeper Inc ($8.1m) and Marian Manor Inc ($8.1m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 27% and program service revenue 65% of the total. Compensation of current officers, directors and key employees was $32k (0.4% of expenses). At year end it held assets of $12.0m against liabilities of $3.2m, net assets of $8.8m.